David B. Weiner - 13 May 2021 Form 4 Insider Report for INOVIO PHARMACEUTICALS, INC. (INO)

Role
Director
Signature
/s/ David B. Weiner
Issuer symbol
INO
Transactions as of
13 May 2021
Net transactions value
-$20,158
Form type
4
Filing time
17 May 2021, 16:27:30 UTC
Next filing
01 Mar 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction INO Common Stock Options Exercise +8,700 +1% 859,836 14 May 2021 Direct F1
transaction INO Common Stock Sale $20,158 -3,045 -0.35% $6.62* 856,791 17 May 2021 Direct F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction INO Common Stock Options Award $0 +27,000 $0.000000 27,000 13 May 2021 Common Stock 27,000 $6.23 Direct F3, F4
transaction INO Restricted Stock Unit Award $0 +18,000 $0.000000 18,000 13 May 2021 Common Stock 18,000 Direct F3, F5
transaction INO Restricted Stock Unit Options Exercise $0 -8,700 -100% $0.000000* 0 14 May 2021 Common Stock 8,700 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each restricted stock unit represents a contingent right to receive one share of common stock. These restricted stock units vested 100% on May 14, 2021.
F2 The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. Reporting person intends to use the proceeds of this sale to pay taxes resulting from the recent vesting of Restricted Stock Units granted by the issuer.
F3 This grant was made pursuant to the issuer's non-employee director compensation policy.
F4 Options to vest 100% on May 13, 2022.
F5 Each restricted stock unit represents a contingent right to receive one share of common stock. These restricted stock units will vest 100% on May 13, 2022.